Latest Stock Market News

ICICI Direct said as a 11 per cent correction in Nifty50 is behind us, investors should focus on building a quality portfolio in a staggered manner from medium to long-term perspective.

“We like Supriya for its niche product portfolio, backward integrated business model and robust financials. It is well placed to tap the opportunity in the pharma API market given its strong pipeline focused on further diversification,” said Sneha Poddar, AVP Retail Research, Motilal Oswal Financial Services.

“The growth story is still unfolding in power, power distribution, renewable energy or for that matter alternative materials and green energy. All these areas, along with infrastructure like ports, roads, railways, airports, are areas where I see a significant amount of traction happening.”

At least 23 emerging and frontier nations have raised rates this year, which could have a moderating impact on inflation and boost real returns from emerging-market assets, especially stocks and local-currency bonds.

Promoters held 0.0 per cent stake in the company as of 30-Sep-2021, while FII and DII ownership stood at 19.14 per cent and 2.65 per cent, respectively.

The stock quoted a 52-week high price of Rs 872.0 and a 52-week low of Rs 675.0.

A total of 8,645 shares changed hands on the counter till 01:03PM (IST).

Cipla Ltd., incorporated in the year 1935, is a Large Cap company (having a market cap of Rs 75418.08 Crore) operating in Pharmaceuticals sector.

The rupee has added around 1.5 per cent against the US dollar since the last week as year-end sales of dollars by exporters, resilience in local equities and market interventions by the RBI has lent a fresh lease of life to the domestic currency.

Shares of BSE have been in demand throughout the last two years as the influx of investors on Dalal Street has increased the number of registered clients. In the last one year, the stock has climbed 216 per cent.